Sodium in PDB 6phv: Spaga Galactose Product Complex Structure

All present enzymatic activity of Spaga Galactose Product Complex Structure:
3.2.1.22;

The structure of Spaga Galactose Product Complex Structure, PDB code: 6phv was solved by B.Pluvinage, A.B.Boraston, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	24.77 / 2.10
Space group	I 2 2 2
Cell size a, b, c (Å), α, β, γ (°)	90.634, 127.283, 151.933, 90.00, 90.00, 90.00
R / Rfree (%)	17.6 / 22.1

The binding sites of Sodium atom in the Spaga Galactose Product Complex Structure (pdb code 6phv). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Spaga Galactose Product Complex Structure, PDB code: 6phv:

Sodium binding site 1 out of 1 in the Spaga Galactose Product Complex Structure


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Spaga Galactose Product Complex Structure within 5.0Å range: probe atom residue distance (Å) B Occ A:Na809 b:24.6 occ:1.00 OG A:SER117 2.6 27.2 1.0 O A:LEU115 2.6 27.2 1.0 O A:PRO112 2.6 29.6 1.0 O A:HOH1356 2.7 33.5 1.0 O A:HOH1251 3.0 36.2 1.0 CB A:SER117 3.7 23.3 1.0 C A:LEU115 3.8 25.0 1.0 C A:PRO112 3.9 29.8 1.0 N A:SER117 4.0 22.8 1.0 N A:LEU115 4.2 24.8 1.0 CA A:SER117 4.5 24.0 1.0 C A:PRO116 4.5 24.8 1.0 N A:GLY114 4.5 29.3 1.0 N A:PRO112 4.5 26.4 1.0 O A:HOH920 4.6 36.4 1.0 CA A:LEU115 4.6 24.6 1.0 CA A:PRO116 4.6 23.3 1.0 N A:PRO116 4.7 22.5 1.0 C A:GLY111 4.7 28.8 1.0 O A:HOH1232 4.7 31.2 1.0 CA A:GLN113 4.7 34.9 1.0 N A:GLN113 4.7 33.3 1.0 CD A:PRO112 4.8 26.7 1.0 CG A:PRO112 4.8 27.2 1.0 O A:HOH1107 4.8 24.3 1.0 CA A:PRO112 4.8 29.0 1.0 C A:GLN113 4.9 31.2 1.0 O A:HOH1254 4.9 26.6 1.0

J.K.Hobbs, E.P.W.Meier, B.Pluvinage, M.A.Mey, A.B.Boraston. Molecular Analysis of An Enigmaticstreptococcus Pneumoniaevirulence Factor: the Raffinose-Family Oligosaccharide Utilization System. J.Biol.Chem. V. 294 17197 2019.
ISSN: ESSN 1083-351X
PubMed: 31591266
DOI: 10.1074/JBC.RA119.010280